RA CAPITAL MANAGEMENT, L.P. Holdings

RA CAPITAL MANAGEMENT, L.P. is an investment fund managing more than 4.69B US dollars. The largest holdings include Ascendis Pharma A/S, Biogen and Cytek Biosciences. In Q3 2022 the fund bought assets of total value of 761.51M US dollars and sold assets of total value of 319.96M US dollars.

$4.68B

portfolio value

+20.61%

quarter

-47.50%

1 year

-157.84%

3 years

-240.90%

5 years

RA CAPITAL MANAGEMENT, L.P. portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	127552000	102156000
Q2 2016	14121000	108249000
Q3 2016	175509000	61188000
Q4 2016	111412000	211014000
Q1 2017	75421000	25005000
Q2 2017	196780000	95558000
Q3 2017	180082000	29378000
Q4 2017	384047000	161122000
Q1 2018	139116000	80616000
Q2 2018	325502000	38694000
Q3 2018	255110000	75094000
Q4 2018	251539000	143854000
Q1 2019	223109000	184664000
Q2 2019	121198000	418859000
Q3 2019	177609000	186846000
Q4 2019	1041600000	88250000
Q1 2020	758627000	110440000
Q2 2020	2086095000	198673000
Q3 2020	1088547000	549939000
Q4 2020	1676000000	336994000
Q1 2021	1000840000	1175058000
Q2 2021	1100926000	586941000
Q3 2021	2086509000	670703000
Q4 2021	243893000	571063000
Q1 2022	361062000	570945000
Q2 2022	356230000	540432000
Q3 2022	761514000	319956000

RA CAPITAL MANAGEMENT, L.P. 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Ascendis Pharma A/S Portfolio share: 16.67% Portfolio value: 781.46M Avg. open price: $77.98 Current price: $119.41 P/L: +53.13% Bought +2.44% shares Q4 2021	share	16.67%	781.46M	$77.98	$119.41	+53.13%	Bought +2.44% shares Q4 2021
Drug Manufacturers—General Biogen Inc. Portfolio share: 5.34% Portfolio value: 250.32M Avg. open price: $203.94 Current price: $292.75 P/L: +43.55% Bought +28.96% shares Q3 2022	share	5.34%	250.32M	$203.94	$292.75	+43.55%	Bought +28.96% shares Q3 2022
Medical Devices Cytek Biosciences, Inc. Portfolio share: 4.20% Portfolio value: 196.96M Avg. open price: $16.63 Current price: $12.33 P/L: -25.86% Bought +39.28% shares Q1 2022	share	4.20%	196.96M	$16.63	$12.33	-25.86%	Bought +39.28% shares Q1 2022
Biotechnology Forma Therapeutics Holdings, Inc. Portfolio share: 3.84% Portfolio value: 179.78M Avg. open price: N/A Current price: $20.01 P/L: N/A N/A Q2 2020	share	3.84%	179.78M	N/A	$20.01	N/A	N/A Q2 2020
Biotechnology Day One Biopharmaceuticals, Inc. Portfolio share: 3.01% Portfolio value: 141.02M Avg. open price: $13.46 Current price: $21.45 P/L: +59.37% Bought +16.18% shares Q2 2022	share	3.01%	141.02M	$13.46	$21.45	+59.37%	Bought +16.18% shares Q2 2022
Biotechnology Aerovate Therapeutics, Inc. Portfolio share: 2.92% Portfolio value: 137.01M Avg. open price: N/A Current price: $18 P/L: N/A N/A Q2 2021	share	2.92%	137.01M	N/A	$18	N/A	N/A Q2 2021
Biotechnology Rhythm Pharmaceuticals, Inc. Portfolio share: 2.86% Portfolio value: 134.04M Avg. open price: $21.54 Current price: $27.14 P/L: +25.98% Bought +12.32% shares Q3 2022	share	2.86%	134.04M	$21.54	$27.14	+25.98%	Bought +12.32% shares Q3 2022
Biotechnology Travere Therapeutics, Inc. Portfolio share: 2.59% Portfolio value: 121.30M Avg. open price: $27.26 Current price: $20.01 P/L: -26.58% Sold -12.32% shares Q1 2022	share	2.59%	121.30M	$27.26	$20.01	-26.58%	Sold -12.32% shares Q1 2022
Biotechnology BELLUS Health Inc. Portfolio share: 2.56% Portfolio value: 120.23M Avg. open price: $9.24 Current price: $10.02 P/L: +8.44% Bought +11.29% shares Q3 2022	share	2.56%	120.23M	$9.24	$10.02	+8.44%	Bought +11.29% shares Q3 2022
Biotechnology Janux Therapeutics, Inc. Portfolio share: 2.50% Portfolio value: 117.40M Avg. open price: N/A Current price: $13.5 P/L: N/A N/A Q2 2021	share	2.50%	117.40M	N/A	$13.5	N/A	N/A Q2 2021
Biotechnology Vaxcyte, Inc. Portfolio share: 2.35% Portfolio value: 109.94M Avg. open price: $25.51 Current price: $44.33 P/L: +73.75% Bought +8.04% shares Q1 2022	share	2.35%	109.94M	$25.51	$44.33	+73.75%	Bought +8.04% shares Q1 2022
Biotechnology DICE Therapeutics, Inc. Portfolio share: 2.25% Portfolio value: 105.63M Avg. open price: N/A Current price: $34.51 P/L: N/A N/A Q3 2021	share	2.25%	105.63M	N/A	$34.51	N/A	N/A Q3 2021
Biotechnology ImmunoGen, Inc. Portfolio share: 2.22% Portfolio value: 103.92M Avg. open price: $4.25 Current price: $5.43 P/L: +27.77% Bought +7.41% shares Q1 2022	share	2.22%	103.92M	$4.25	$5.43	+27.77%	Bought +7.41% shares Q1 2022
Biotechnology Nkarta, Inc. Portfolio share: 2.19% Portfolio value: 102.71M Avg. open price: $11.38 Current price: $8.15 P/L: -28.38% Bought +39.25% shares Q2 2022	share	2.19%	102.71M	$11.38	$8.15	-28.38%	Bought +39.25% shares Q2 2022
Biotechnology Acumen Pharmaceuticals, Inc. Portfolio share: 2.09% Portfolio value: 98.00M Avg. open price: N/A Current price: $5.6 P/L: N/A N/A Q3 2021	share	2.09%	98.00M	N/A	$5.6	N/A	N/A Q3 2021
Biotechnology Legend Biotech Corporation Portfolio share: 2.04% Portfolio value: 95.41M Avg. open price: N/A Current price: $50.99 P/L: N/A N/A Q3 2022	share	2.04%	95.41M	N/A	$50.99	N/A	N/A Q3 2022
Biotechnology iTeos Therapeutics, Inc. Portfolio share: 1.80% Portfolio value: 84.14M Avg. open price: $34.18 Current price: $20.04 P/L: -41.37% Bought 0.00% shares Q2 2021	share	1.80%	84.14M	$34.18	$20.04	-41.37%	Bought 0.00% shares Q2 2021
Biotechnology Relmada Therapeutics, Inc. Portfolio share: 1.58% Portfolio value: 74.04M Avg. open price: $39 Current price: $4.45 P/L: -88.59% N/A Q4 2021	share	1.58%	74.04M	$39	$4.45	-88.59%	N/A Q4 2021
Biotechnology PepGen Inc. Portfolio share: 1.58% Portfolio value: 73.83M Avg. open price: N/A Current price: $14.98 P/L: N/A N/A Q2 2022	share	1.58%	73.83M	N/A	$14.98	N/A	N/A Q2 2022
Biotechnology Geron Corporation Portfolio share: 1.50% Portfolio value: 70.49M Avg. open price: N/A Current price: $2.29 P/L: N/A N/A Q2 2020	share	1.50%	70.49M	N/A	$2.29	N/A	N/A Q2 2020
Diagnostics & Research Aclaris Therapeutics, Inc. Portfolio share: 1.48% Portfolio value: 69.23M Avg. open price: $17.47 Current price: $15.66 P/L: -10.37% Bought +141.96% shares Q2 2022	share	1.48%	69.23M	$17.47	$15.66	-10.37%	Bought +141.96% shares Q2 2022
Biotechnology Third Harmonic Bio, Inc. Portfolio share: 1.41% Portfolio value: 65.93M Avg. open price: N/A Current price: $22 P/L: N/A N/A Q3 2022	share	1.41%	65.93M	N/A	$22	N/A	N/A Q3 2022
Biotechnology AN2 Therapeutics, Inc. Portfolio share: 1.40% Portfolio value: 65.58M Avg. open price: $13.35 Current price: $9.14 P/L: -31.53% Bought +0.67% shares Q3 2022	share	1.40%	65.58M	$13.35	$9.14	-31.53%	Bought +0.67% shares Q3 2022
Biotechnology Tyra Biosciences, Inc. Portfolio share: 1.36% Portfolio value: 63.60M Avg. open price: N/A Current price: $6.89 P/L: N/A N/A Q3 2021	share	1.36%	63.60M	N/A	$6.89	N/A	N/A Q3 2021
Biotechnology Wave Life Sciences Ltd. Portfolio share: 1.32% Portfolio value: 62.09M Avg. open price: $3.87 Current price: $4.25 P/L: +9.86% Bought +121.24% shares Q2 2022	share	1.32%	62.09M	$3.87	$4.25	+9.86%	Bought +121.24% shares Q2 2022
Biotechnology Verona Pharma plc Portfolio share: 1.32% Portfolio value: 61.83M Avg. open price: $4.19 Current price: $13.57 P/L: +223.87% Bought +18.63% shares Q3 2022	share	1.32%	61.83M	$4.19	$13.57	+223.87%	Bought +18.63% shares Q3 2022
Biotechnology Cogent Biosciences, Inc. Portfolio share: 1.28% Portfolio value: 59.88M Avg. open price: N/A Current price: $12.5 P/L: N/A N/A Q3 2022	share	1.28%	59.88M	N/A	$12.5	N/A	N/A Q3 2022
Medical Instruments & Supplies NanoString Technologies, Inc. Portfolio share: 1.25% Portfolio value: 58.77M Avg. open price: $12.7 Current price: $7.06 P/L: -44.41% Bought +28.40% shares Q3 2022	share	1.25%	58.77M	$12.7	$7.06	-44.41%	Bought +28.40% shares Q3 2022
Biotechnology Celldex Therapeutics, Inc. Portfolio share: 1.24% Portfolio value: 58.32M Avg. open price: $45.41 Current price: $36.66 P/L: -19.26% Bought +14.97% shares Q1 2022	share	1.24%	58.32M	$45.41	$36.66	-19.26%	Bought +14.97% shares Q1 2022
Biotechnology GH Research PLC Portfolio share: 1.21% Portfolio value: 56.91M Avg. open price: $22.05 Current price: $11.4 P/L: -48.30% Bought +1.47% shares Q2 2022	share	1.21%	56.91M	$22.05	$11.4	-48.30%	Bought +1.47% shares Q2 2022
Biotechnology Fulcrum Therapeutics, Inc. Portfolio share: 1.21% Portfolio value: 56.63M Avg. open price: N/A Current price: $6.56 P/L: N/A N/A Q3 2022	share	1.21%	56.63M	N/A	$6.56	N/A	N/A Q3 2022
Biotechnology Kinnate Biopharma Inc. Portfolio share: 1.09% Portfolio value: 50.95M Avg. open price: $18.16 Current price: $7.05 P/L: -61.18% Bought +18.68% shares Q1 2022	share	1.09%	50.95M	$18.16	$7.05	-61.18%	Bought +18.68% shares Q1 2022
Biotechnology Enanta Pharmaceuticals, Inc. Portfolio share: 0.99% Portfolio value: 46.51M Avg. open price: N/A Current price: $43.06 P/L: N/A Sold -7.00% shares Q2 2022	share	0.99%	46.51M	N/A	$43.06	N/A	Sold -7.00% shares Q2 2022
Biotechnology Design Therapeutics, Inc. Portfolio share: 0.99% Portfolio value: 46.36M Avg. open price: $14 Current price: $13.67 P/L: -2.36% Bought +26.83% shares Q3 2022	share	0.99%	46.36M	$14	$13.67	-2.36%	Bought +26.83% shares Q3 2022
Biotechnology 89bio, Inc. Portfolio share: 0.96% Portfolio value: 45.06M Avg. open price: $10.27 Current price: $8.34 P/L: -18.76% Bought +56.73% shares Q2 2022	share	0.96%	45.06M	$10.27	$8.34	-18.76%	Bought +56.73% shares Q2 2022
Biotechnology Vor Biopharma Inc. Portfolio share: 0.94% Portfolio value: 44.26M Avg. open price: N/A Current price: $4.72 P/L: N/A N/A Q1 2021	share	0.94%	44.26M	N/A	$4.72	N/A	N/A Q1 2021
Biotechnology Eliem Therapeutics, Inc. Portfolio share: 0.91% Portfolio value: 42.47M Avg. open price: N/A Current price: $2.51 P/L: N/A N/A Q3 2021	share	0.91%	42.47M	N/A	$2.51	N/A	N/A Q3 2021
Biotechnology Instil Bio, Inc. Portfolio share: 0.79% Portfolio value: 37.12M Avg. open price: $10.75 Current price: $1.22 P/L: -88.65% Bought +57.49% shares Q2 2022	share	0.79%	37.12M	$10.75	$1.22	-88.65%	Bought +57.49% shares Q2 2022
Medical Devices RxSight, Inc. Portfolio share: 0.78% Portfolio value: 36.63M Avg. open price: N/A Current price: $13.83 P/L: N/A N/A Q3 2021	share	0.78%	36.63M	N/A	$13.83	N/A	N/A Q3 2021
Biotechnology Satsuma Pharmaceuticals, Inc. Portfolio share: 0.76% Portfolio value: 35.48M Avg. open price: $4.61 Current price: $0.89 P/L: -80.65% Bought +26.32% shares Q1 2021	share	0.76%	35.48M	$4.61	$0.89	-80.65%	Bought +26.32% shares Q1 2021
Biotechnology Avidity Biosciences, Inc. Portfolio share: 0.76% Portfolio value: 35.39M Avg. open price: $23.93 Current price: $11.18 P/L: -53.28% Bought +411.64% shares Q1 2022	share	0.76%	35.39M	$23.93	$11.18	-53.28%	Bought +411.64% shares Q1 2022
Biotechnology Vera Therapeutics, Inc. Portfolio share: 0.72% Portfolio value: 33.64M Avg. open price: N/A Current price: $16.19 P/L: N/A Sold -19.70% shares Q2 2022	share	0.72%	33.64M	N/A	$16.19	N/A	Sold -19.70% shares Q2 2022
Biotechnology Rocket Pharmaceuticals, Inc. Portfolio share: 0.72% Portfolio value: 33.63M Avg. open price: N/A Current price: $19.03 P/L: N/A Sold -1.35% shares Q1 2021	share	0.72%	33.63M	N/A	$19.03	N/A	Sold -1.35% shares Q1 2021
Biotechnology Akero Therapeutics, Inc. Portfolio share: 0.70% Portfolio value: 32.65M Avg. open price: N/A Current price: $44.04 P/L: N/A N/A Q3 2022	share	0.70%	32.65M	N/A	$44.04	N/A	N/A Q3 2022
Biotechnology Alpine Immune Sciences, Inc. Portfolio share: 0.67% Portfolio value: 31.36M Avg. open price: N/A Current price: $6.78 P/L: N/A N/A Q3 2022	share	0.67%	31.36M	N/A	$6.78	N/A	N/A Q3 2022
Biotechnology HilleVax, Inc. Portfolio share: 0.64% Portfolio value: 30.07M Avg. open price: N/A Current price: $17.5 P/L: N/A N/A Q2 2022	share	0.64%	30.07M	N/A	$17.5	N/A	N/A Q2 2022
Biotechnology Adicet Bio, Inc. Portfolio share: 0.62% Portfolio value: 29.28M Avg. open price: N/A Current price: $20.2 P/L: N/A N/A Q3 2022	share	0.62%	29.28M	N/A	$20.2	N/A	N/A Q3 2022
Biotechnology EyePoint Pharmaceuticals, Inc. Portfolio share: 0.57% Portfolio value: 26.66M Avg. open price: $9.77 Current price: $3.33 P/L: -65.92% Bought +52.48% shares Q4 2021	share	0.57%	26.66M	$9.77	$3.33	-65.92%	Bought +52.48% shares Q4 2021
Biotechnology Milestone Pharmaceuticals Inc. Portfolio share: 0.44% Portfolio value: 20.64M Avg. open price: N/A Current price: $4.75 P/L: N/A Sold -3.49% shares Q1 2021	share	0.44%	20.64M	N/A	$4.75	N/A	Sold -3.49% shares Q1 2021
Biotechnology PMV Pharmaceuticals, Inc. Portfolio share: 0.43% Portfolio value: 20.35M Avg. open price: N/A Current price: $9.89 P/L: N/A N/A Q3 2020	share	0.43%	20.35M	N/A	$9.89	N/A	N/A Q3 2020
Biotechnology Werewolf Therapeutics, Inc. Portfolio share: 0.41% Portfolio value: 19.35M Avg. open price: N/A Current price: $1.75 P/L: N/A N/A Q2 2021	share	0.41%	19.35M	N/A	$1.75	N/A	N/A Q2 2021
Biotechnology Icosavax, Inc. Portfolio share: 0.40% Portfolio value: 18.84M Avg. open price: $23.02 Current price: $3.19 P/L: -86.14% Bought +3.19% shares Q1 2022	share	0.40%	18.84M	$23.02	$3.19	-86.14%	Bought +3.19% shares Q1 2022
Biotechnology Viridian Therapeutics, Inc. Portfolio share: 0.39% Portfolio value: 18.04M Avg. open price: N/A Current price: $26.84 P/L: N/A N/A Q3 2022	share	0.39%	18.04M	N/A	$26.84	N/A	N/A Q3 2022
Biotechnology Relay Therapeutics, Inc. Portfolio share: 0.34% Portfolio value: 16.05M Avg. open price: $16.75 Current price: $18.36 P/L: +9.61% Bought +30.70% shares Q3 2022	share	0.34%	16.05M	$16.75	$18.36	+9.61%	Bought +30.70% shares Q3 2022
Shell Companies DA32 Life Science Tech Acquisition Corp. Portfolio share: 0.31% Portfolio value: 14.59M Avg. open price: N/A Current price: $9.89 P/L: N/A N/A Q3 2021	share	0.31%	14.59M	N/A	$9.89	N/A	N/A Q3 2021
Shell Companies BCLS Acquisition Corp. Portfolio share: 0.27% Portfolio value: 12.52M Avg. open price: N/A Current price: $10.04 P/L: N/A N/A Q4 2020	share	0.27%	12.52M	N/A	$10.04	N/A	N/A Q4 2020
Biotechnology Pardes Biosciences, Inc. Portfolio share: 0.24% Portfolio value: 11.42M Avg. open price: $17.02 Current price: $1.1 P/L: -93.54% Bought +97.47% shares Q1 2022	share	0.24%	11.42M	$17.02	$1.1	-93.54%	Bought +97.47% shares Q1 2022
Biotechnology Achilles Therapeutics plc Portfolio share: 0.24% Portfolio value: 11.33M Avg. open price: $16.55 Current price: $1.71 P/L: -89.67% Bought +261.06% shares Q2 2021	share	0.24%	11.33M	$16.55	$1.71	-89.67%	Bought +261.06% shares Q2 2021
Shell Companies Frazier Lifesciences Acquisition Corporation Portfolio share: 0.21% Portfolio value: 9.98M Avg. open price: N/A Current price: $9.5 P/L: N/A N/A Q4 2020	share	0.21%	9.98M	N/A	$9.5	N/A	N/A Q4 2020
Shell Companies ARYA Sciences Acquisition Corp V Portfolio share: 0.21% Portfolio value: 9.8M Avg. open price: N/A Current price: $9.97 P/L: N/A N/A Q3 2021	share	0.21%	9.8M	N/A	$9.97	N/A	N/A Q3 2021
Biotechnology Connect Biopharma Holdings Limited Portfolio share: 0.19% Portfolio value: 9.01M Avg. open price: $18.5 Current price: $0.71 P/L: -96.15% Bought +133.72% shares Q2 2021	share	0.19%	9.01M	$18.5	$0.71	-96.15%	Bought +133.72% shares Q2 2021
Biotechnology Aadi Bioscience, Inc. Portfolio share: 0.18% Portfolio value: 8.34M Avg. open price: $12.32 Current price: $13.42 P/L: +8.89% Bought +54.09% shares Q3 2022	share	0.18%	8.34M	$12.32	$13.42	+8.89%	Bought +54.09% shares Q3 2022
Shell Companies 5:01 Acquisition Corp. Portfolio share: 0.16% Portfolio value: 7.5M Avg. open price: N/A Current price: $10 P/L: N/A N/A Q4 2020	share	0.16%	7.5M	N/A	$10	N/A	N/A Q4 2020
Biotechnology Concert Pharmaceuticals, Inc. Portfolio share: 0.16% Portfolio value: 7.29M Avg. open price: $10.93 Current price: $4.76 P/L: -56.45% Sold -67.09% shares Q3 2022	share	0.16%	7.29M	$10.93	$4.76	-56.45%	Sold -67.09% shares Q3 2022
Biotechnology DBV Technologies S.A. Portfolio share: 0.14% Portfolio value: 6.59M Avg. open price: N/A Current price: $1.31 P/L: N/A N/A Q3 2022	share	0.14%	6.59M	N/A	$1.31	N/A	N/A Q3 2022
Shell Companies Health Sciences Acquisitions Corporation 2 Portfolio share: 0.13% Portfolio value: 6.04M Avg. open price: N/A Current price: $9.96 P/L: N/A Sold -2.35% shares Q3 2022	share	0.13%	6.04M	N/A	$9.96	N/A	Sold -2.35% shares Q3 2022
Biotechnology Solid Biosciences Inc. Portfolio share: 0.12% Portfolio value: 5.77M Avg. open price: $4.12 Current price: $6.46 P/L: +56.62% Bought +23.97% shares Q1 2021	share	0.12%	5.77M	$4.12	$6.46	+56.62%	Bought +23.97% shares Q1 2021
Biotechnology Athira Pharma, Inc. Portfolio share: 0.12% Portfolio value: 5.57M Avg. open price: N/A Current price: $2.94 P/L: N/A N/A Q2 2022	share	0.12%	5.57M	N/A	$2.94	N/A	N/A Q2 2022
Biotechnology Magenta Therapeutics, Inc. Portfolio share: 0.11% Portfolio value: 5.05M Avg. open price: N/A Current price: $1.24 P/L: N/A N/A Q3 2022	share	0.11%	5.05M	N/A	$1.24	N/A	N/A Q3 2022
Biotechnology IO Biotech, Inc. Portfolio share: 0.11% Portfolio value: 5.03M Avg. open price: N/A Current price: $2.81 P/L: N/A N/A Q4 2021	share	0.11%	5.03M	N/A	$2.81	N/A	N/A Q4 2021
Biotechnology Tenaya Therapeutics, Inc. Portfolio share: 0.10% Portfolio value: 4.64M Avg. open price: N/A Current price: $2.42 P/L: N/A Sold -54.89% shares Q3 2022	share	0.10%	4.64M	N/A	$2.42	N/A	Sold -54.89% shares Q3 2022
Biotechnology Synlogic, Inc. Portfolio share: 0.09% Portfolio value: 4.38M Avg. open price: N/A Current price: $0.74 P/L: N/A Sold -20.73% shares Q3 2022	share	0.09%	4.38M	N/A	$0.74	N/A	Sold -20.73% shares Q3 2022
Biotechnology Black Diamond Therapeutics, Inc. Portfolio share: 0.09% Portfolio value: 4.37M Avg. open price: N/A Current price: $1.86 P/L: N/A N/A Q1 2020	share	0.09%	4.37M	N/A	$1.86	N/A	N/A Q1 2020
Medical Devices CVRx, Inc. Portfolio share: 0.05% Portfolio value: 2.56M Avg. open price: N/A Current price: $13.5 P/L: N/A N/A Q2 2021	share	0.05%	2.56M	N/A	$13.5	N/A	N/A Q2 2021
Biotechnology Entera Bio Ltd. Portfolio share: 0.05% Portfolio value: 2.16M Avg. open price: N/A Current price: $0.7 P/L: N/A Sold -11.50% shares Q3 2022	share	0.05%	2.16M	N/A	$0.7	N/A	Sold -11.50% shares Q3 2022
Biotechnology Fusion Pharmaceuticals Inc. Portfolio share: 0.04% Portfolio value: 1.98M Avg. open price: N/A Current price: $2.36 P/L: N/A N/A Q3 2022	share	0.04%	1.98M	N/A	$2.36	N/A	N/A Q3 2022
Biotechnology Pyxis Oncology, Inc. Portfolio share: 0.03% Portfolio value: 1.50M Avg. open price: N/A Current price: $1.29 P/L: N/A Sold -19.80% shares Q3 2022	share	0.03%	1.50M	N/A	$1.29	N/A	Sold -19.80% shares Q3 2022
Biotechnology Sensei Biotherapeutics, Inc. Portfolio share: 0.02% Portfolio value: 1.05M Avg. open price: N/A Current price: $1.43 P/L: N/A Sold -5.53% shares Q3 2022	share	0.02%	1.05M	N/A	$1.43	N/A	Sold -5.53% shares Q3 2022
Biotechnology Bolt Biotherapeutics, Inc. Portfolio share: 0.02% Portfolio value: 789K Avg. open price: $2.04 Current price: $1.4 P/L: -31.37% Bought +18.50% shares Q3 2022	share	0.02%	789K	$2.04	$1.4	-31.37%	Bought +18.50% shares Q3 2022
Biotechnology Aptinyx Inc. Portfolio share: 0.02% Portfolio value: 720K Avg. open price: N/A Current price: $0.25 P/L: N/A N/A Q3 2022	share	0.02%	720K	N/A	$0.25	N/A	N/A Q3 2022
Biotechnology Aeglea BioTherapeutics, Inc. Portfolio share: 0.00% Portfolio value: 5K Avg. open price: N/A Current price: $0.47 P/L: N/A N/A Q3 2022	share	0.00%	5K	N/A	$0.47	N/A	N/A Q3 2022
Biotechnology Terns Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $6.09 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$6.09	N/A	Sold -100.00% shares Q3 2022
Diagnostics & Research Guardant Health, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $51.95 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$51.95	N/A	Sold -100.00% shares Q3 2022
Biotechnology Larimar Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $3.15 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$3.15	N/A	Sold -100.00% shares Q3 2022
Diagnostics & Research Standard BioTools Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.43 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.43	N/A	Sold -100.00% shares Q3 2022
Biotechnology LianBio Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.49 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.49	N/A	Sold -100.00% shares Q3 2022
Biotechnology Dyne Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $11.47 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$11.47	N/A	Sold -100.00% shares Q3 2022
Diagnostics & Research Natera, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $40.39 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$40.39	N/A	Sold -100.00% shares Q3 2022
Biotechnology Olema Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.79 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.79	N/A	Sold -100.00% shares Q3 2022
Biotechnology Orchard Therapeutics plc Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $11.52 Current price: $0.45 P/L: -96.09% Sold -100.00% shares Q3 2022	share	0.00%	0	$11.52	$0.45	-96.09%	Sold -100.00% shares Q3 2022
Biotechnology Otonomy, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $1.92 Current price: $0.13 P/L: -93.18% Sold -100.00% shares Q3 2022	share	0.00%	0	$1.92	$0.13	-93.18%	Sold -100.00% shares Q3 2022
Biotechnology POINT Biopharma Global Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $6.72 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$6.72	N/A	Sold -100.00% shares Q3 2022
Biotechnology Century Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $10.25 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$10.25	N/A	Sold -100.00% shares Q3 2022
Biotechnology Caladrius Biosciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.43 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.43	N/A	Sold -100.00% shares Q3 2022
Biotechnology BioAtla, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $10.52 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$10.52	N/A	Sold -100.00% shares Q3 2022
Biotechnology Biomea Fusion, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $6.77 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$6.77	N/A	Sold -100.00% shares Q3 2022
Biotechnology AVROBIO, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.89 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.89	N/A	Sold -100.00% shares Q3 2022
Biotechnology Astria Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $10.32 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$10.32	N/A	Sold -100.00% shares Q3 2022
Biotechnology Veru Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $5.82 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$5.82	N/A	Sold -100.00% shares Q3 2022
Biotechnology Adverum Biotechnologies, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $17.81 Current price: $0.66 P/L: -96.29% Sold -100.00% shares Q3 2022	share	0.00%	0	$17.81	$0.66	-96.29%	Sold -100.00% shares Q3 2022
Biotechnology Xilio Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.43 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.43	N/A	Sold -100.00% shares Q3 2022

Showing TOP 101 RA CAPITAL MANAGEMENT, L.P.'s 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of RA CAPITAL MANAGEMENT, L.P.?

The biggest position of the RA CAPITAL MANAGEMENT, L.P. is Ascendis Pharma A/S (ASND) with 16.67% portfolio share worth of 781.46M US dollars.

Top 5 RA CAPITAL MANAGEMENT, L.P.'s holdings represent 33.06% of the portfolio:

Ascendis Pharma A/S (ASND) – 16.67%
Biogen Inc. (BIIB) – 5.34%
Cytek Biosciences, Inc. (CTKB) – 4.2%
Forma Therapeutics Holdings, Inc. (FMTX) – 3.84%
Day One Biopharmaceuticals, Inc. (DAWN) – 3.01%

Who is the portfolio manager of RA CAPITAL MANAGEMENT, L.P.?

The portfolio manager of the RA CAPITAL MANAGEMENT, L.P. is .

What is the total asset value of the RA CAPITAL MANAGEMENT, L.P. portfolio?

RA CAPITAL MANAGEMENT, L.P. total asset value (portfolio value) is 4.69B US dollars.

Who is ?

is the portfolio manager of the RA CAPITAL MANAGEMENT, L.P..

What is (RA CAPITAL MANAGEMENT, L.P.) fund performance?

RA CAPITAL MANAGEMENT, L.P.'s quarterly performance is +20.61%, annualy -47.50%. In the past 3 years, the value of 's portfolio has decreased by -158%. In the past 5 years, the value of the portfolio has decreased by -241%.

What is the RA CAPITAL MANAGEMENT, L.P. CIK?

RA CAPITAL MANAGEMENT, L.P.'s Central Index Key is 0001346824 .

RA CAPITAL MANAGEMENT, L.P. Holdings

RA CAPITAL MANAGEMENT, L.P. portfolio value:

RA CAPITAL MANAGEMENT, L.P. quarter portfolio value change:

RA CAPITAL MANAGEMENT, L.P. 1 year portfolio value change:

RA CAPITAL MANAGEMENT, L.P. 3 years portfolio value change:

RA CAPITAL MANAGEMENT, L.P. 5 years portfolio value change: